| 361/949 | US=60 / Biol/Mol Hietanen S. Apoptosis in carcinogenesis and chemotherapy of the uterine cervix. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 51-73. ISBN 978-1-4020-9596-2. APOPTOSE; MORTE CELULAR PROGRAMADA; QUIMIOTERAPIA; CARCINOGENESE DO COLO UTERINO; PAPILOMAVIRUS HUMANO (HPV) |
| 362/949 | US=60 / Biol/Mol Yang SY, Sales KM, Winslet MC. Apoptosis in colorectal tumorigenesis and chemotherapy. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 75-109. ISBN 978-1-4020-9596-2. APOPTOSE; MORTE CELULAR PROGRAMADA; QUIMIOTERAPIA; CARCINOGENESE DO COLO UTERINO; CANCER COLORRETAL; PAPILOMAVIRUS HUMANO (HPV); CARCINOMA COLORRETAL. EPIDEMIOLOGIA; CARCINOMA COLORRETAL. ETIOLOGIA; CARCINOMA COLORRETAL. PATOLOGIA; CARCINOMA COLORRETAL. TRATAMENTO; TUMORIGENESE COLORRETAL; ADENOMA; MUTACAO GENICA |
| 363/949 | US=60 / Biol/Mol Nicholl MB, Hoon DSB. Apoptosis in cutaneous melanoma. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 111-25. ISBN 978-1-4020-9596-2. APOPTOSE; MORTE CELULAR PROGRAMADA; MELANOMA CUTANEO; APAF-1; SURVIVINA; INIBIDORES DE APOPTOSE |
| 364/949 | US=60 / Biol/Mol Li Y, Martin RCG. Apoptosis in carcinogenesis and chemotherapy - esophageal cancer. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 127-56. ISBN 978-1-4020-9596-2. APOPTOSE; MORTE CELULAR PROGRAMADA; CARCINOGENESE; QUIMIOTERAPIA; CANCER DE ESOFAGO; VIAS DE SINALIZACAO; CARCINOMA ESOFAGICO; ADENOCARCINOMA ESOFAGICO |
| 365/949 | US=60 / Biol/Mol Balcer-Kubiczek EK, Garofalo MC. Molecular targets in gastric cancer and apoptosis. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 157-92. ISBN 978-1-4020-9596-2. APOPTOSE; MORTE CELULAR PROGRAMADA; ALVOS MOLECULARES; CANCER GASTRICO; REGULADORES DO CANCER; MICRORNA; CELULAS-TRONCO; CANCER GASTRICO. EPIDEMIOLOGIA; CANCER GASTRICO. CLASSIFICACAO PATOLOGICA; CANCER GASTRICO. TRATAMENTO; CANCER GASTRICO. ASPECTOS MOLECULARES; VIAS APOPTOTICAS |
| 366/949 | US=60 / Biol/Mol Yarde DN, Tao J. Apoptosis and the tumor microenvironment in hematologic malignancies. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 193-218. ISBN 978-1-4020-9596-2. APOPTOSE; MORTE CELULAR PROGRAMADA; RESISTENCIA A DROGA; LEUCEMIA; LINFOMA; MIELOMA MULTIPLO; MICROAMBIENTE DO TUMOR |
| 367/949 | US=60 / Biol/Mol Ma S, Chen GG, Lai PBS. Bcl-2 family members in hepatocellular carcinoma (HCC) - mechanisms and therapeutic potentials. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 219-35. ISBN 978-1-4020-9596-2. APOPTOSE; MORTE CELULAR PROGRAMADA; FAMILIA BCL-2; DOMINIOS BH3; CARCINOMA HEPATOCELULAR; CANCER DE FIGADO; CANCER HEPATICO; HEPATOCARCINOGENESE |
| 368/949 | US=60 / Biol/Mol Redondo M, Fúnez R, Esteban F. Apoptosis in the development and treatment of laryngeal cancer: role of p53, Bcl-2 and clusterin. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 237-49. ISBN 978-1-4020-9596-2. APOPTOSE; MORTE CELULAR PROGRAMADA; CANCER DE LARINGE; P53; BCL-2; CLUSTERINA |
| 369/949 | US=60 / Biol/Mol Leung KC, Chen GG. Cyclooxygenase 2 and its metabolites: implications for lung cancer therapy. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 251-72. ISBN 978-1-4020-9596-2. APOPTOSE; MORTE CELULAR PROGRAMADA; CANCER DE PULMAO; CICLOOXIGENASE 2; PROSTAGLANDINA; COX-2; QUIMIOTERAPIA |
| 370/949 | US=60 / Biol/Mol Lee MH, Yang H, Zhao R, Yeung SCJ. Roles of negative and positive growth regulators in nasopharyngeal carcinoma. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 273-94. ISBN 978-1-4020-9596-2. APOPTOSE; MORTE CELULAR PROGRAMADA; CANCER NASOFARINGEO; REGULADORES DE CRESCIMENTO; CICLO CECLULAR; CARCINOMA NASOFARINGEO; SINALIZACAO DE TRANSDUCAO; REGULADORES DE CRESCIMENTO NEGATIVO; REGULADORES DE CRESCIMENTO POSITIVO |
| 371/949 | US=60 / Biol/Mol Alin N, MacLeod S, Hine RJ, Chowdhury P. Cellular signaling mechanisms in pancreatic apoptosis. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 295-325. ISBN 978-1-4020-9596-2. APOPTOSE; MORTE CELULAR PROGRAMADA; MECANISMOS DE SINALIZACAO DE APOPTOSE; FOSFATOS DE INOSITOL; NUTRICAO; CARCINOGENESE PANCREATICA; CANCER DE PANCREAS; BIOMARCADORES; INIBIDORES DE CASPASES; FAMILIA IAP; MECANISMOS ACOPLADOS A PROTEINA- G; POLIFOSFATOS DE INOSITOL; BIOMARCADORES; DIETA; ESTRESSE OXIDATIVO |
| 372/949 | US=60 / Biol/Mol Dinnen RD, Petrylak DP, Fine RL. Strategies to circumvent resistance to apoptosis in prostate cancer cells by targeted necrosis. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 327-46. ISBN 978-1-4020-9596-2. APOPTOSE; MORTE CELULAR PROGRAMADA; RESISTENCIA A APOPTOSE; CANCER DE PROSTATA; NECROSE; P53; ESPECIES REATIVAS DE OXIGENIO |
| 373/949 | US=60 / Biol/Mol Liu ZM, Chen GG. Carcinogenesis and therapeutic strategies for thyroid cancer. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 347-74. ISBN 978-1-4020-9596-2. APOPTOSE; MORTE CELULAR PROGRAMADA; CARCINOGENESE; CANCER DA TIREOIDE; TERAPIA ANTI-CANCER; ANGIOGENESE |
| 374/949 | US=64 / Biol/Mol Brusselmans K, Swinnen JV. The lipogenic switch in cancer. In: Singh KK, Costello LC. Mitochondria and cancer. New York: Spriger, 2009. p. 39-59. ISBN 978-0-387-84834-1. INTERRUPTOR LIPOGENIC NO CANCER; LIPIDIOS NA FISIOLOGIA CELULAR NORMAL; INTERRUPTOR LIPOGENIC EM CELULAS CANCEROSAS; MECANISMO DO INTERRUPTOR LIPOGENIC NO CANCER; ENZIMAS LIPOGENICAS; INTERVENCAO ANTINEOPLASICO; IMPACTO DA LIPOGENESE; BIOLOGIA CELULAR DO TUMOR |
| 375/949 | US=64 / Biol/Mol Franklin RB, Costello LC. Citrate metabolism in prostate and cancers. In: Singh KK, Costello LC. Mitochondria and cancer. New York: Spriger, 2009. p. 61-78. ISBN 978-0-387-84834-1. METABOLISMO DE CITRATO NA PROSTATA E CANCER; PAPEIS METABOLICOS DE CITRATO; CELULAS DE MAMIFEROS; CITRATO DE CANCER DE PROSTATA; ZINCO E METABOLISMO MITOCONDRIAL; AXIMS DE RELACOES DE ATIVIDADE CELULAR; METABOLISMO CITRATO DE CELULAS EPITELIAIS DA PROSTATA NORMAIS; RELACAO CITRATO ALTERADAS NO CANCER DE PROSTATA; PAPEL DA GLICOLISE ACELERADA NO METABOLISMO DA CELULA TUMORAL |
| 376/949 | US=64 / Biol/Mol Costello LC, Franklin RB. Integration of genetic, proteomic, and metabolic approaches in tumor cell metabolism. In: Singh KK, Costello LC. Mitochondria and cancer. New York: Spriger, 2009. p. 79-92. ISBN 978-0-387-84834-1. METABOLICA NO METABOLISMO DAS CELULAS TUMORAIS; RELACOES DE ATIVIDADE CELULAR; METABOLISMO CELULAR E MALIGNIDADE; CELULA MALIGNA DITA O SEU METABOLISMO; METABOLICA DE CELULAS MALIGNAS; IMPORTANTES CELULARES BIOQUIMICAS; METABOLICA RELACOES; MITOCONDRIAIS ENZIMATICOS; METABOLISMO ANALISES; CONCEITO DE GENES METABOLICOS; PROTEOMICA PARA O METABOLISMO DAS CELULAS TUMORAIS INTERMEDIARIO |
| 377/949 | US=64 / Biol/Mol Scatena R, Botoni P, Giardina B. Mitochondrial respiration and differentiation. In: Singh KK, Costello LC. Mitochondria and cancer. New York: Spriger, 2009. p. 93-102. ISBN 978-0-387-84834-1. |
| 378/949 | US=66 / Câncer Baeten CIM. Biomarkers of cell proliferation in carcinomas: detection of angiogenesis and infiltrated leukocytes. In: Kozlov SV. Inflammation and cancer: methods and protocols: experimental models and practical approaches. New York: Humana Press, 2009. p. 61-73. (Methods in Molecular Biology n.511 - Springer Protocols) ISBN 978-1-934115-14-5. CITOMETRIA DE FLUXO; BIOMARCADORES DE PROLIFERACAO CELULAR EM CARCINOMAS; DETECCAO DE ANGIOGENESE; LEUCOCITOS INFILTRADOS; TUMOR; ANGIOGENESE; LEUCOCITOS; EXPRESSAO ADESAO MOLECULAR |
| 379/949 | US=66 / Biol/Mol Hiyama K, Hiyana E, Shay JW. Telomeres and telomerase in humans. In: Hiyama K, editor. Telomeres and telomerase in cancer. New York: Springer, 2009. p. 3-21. (Cancer Drug Discovery and Development) ISBN 978-1-60327-306-0. TELOMEROS E TELOMERASE EM HUMANOS; TELOMEROS; TELOMERASE; CELULA GERMINAL; CELULA CANCEROSA; CELULAS-TRONCO; IMORTALIZACAO CELULAR; TELOMERO DISFUNCAO; FIM-REPLICACAO PROBLEMA; STAFE MORTALIDADE; LIMITE DE HAYFLICK; FIM-REPLICACAO PROBLEMA; FASE DE MORTALIDADE; LIMITE DE HAYFLICK; TERT; TERC |
| 380/949 | US=67 / Câncer Srikanthan P, Pessin JE, Bar RS. Type 2 Diabetes. In: Bar RS, editor. Early diagnosis and treatment of endocrine disorders. New Jersey: Humana Press, 2009. p. 87-109. ISBN 978-1-58829-193-6. DIABETES TIPO 2; RESPOSTA CELULAR A INSULINA; DIABETES TIPO 2 E IGT; EQUIPES MULTIDISCIPLINARES DE TRATAMENTO |